CORICIDIN D NASAL AND SINUS CONGESTION TABLETS DIN 02244653
Status: Cancelled Pre Market
Holder: SCHERING-PLOUGH HEALTHCARE PRODUCTS CANADA, A DIVISION OF SCHERING CANADA INC.
Molecule: PSEUDOEPHEDRINE SULFATE
Health Canada record
| Active ingredient(s) | PSEUDOEPHEDRINE SULFATE 120 MG; DEXBROMPHENIRAMINE MALEATE 6 MG |
|---|---|
| Dosage form | Tablet (Extended-Release) |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | R01BA52 PSEUDOEPHEDRINE, COMBINATIONS |
| Original market date | |
| Current status date | 01-Sep-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Schering-Plough Mexico S.A. DE C.V. — licence , not currently licensed, last inspection rating C (2022-08-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PSEUDOEPHEDRINE SULFATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02260557 | CLARITIN ALLERGY + SINUS EXTRA STRENGTH | BAYER INC | Tablet (Immediate- And Extended-Release) | PSEUDOEPHEDRINE SULFATE 240 MG; LORATADINE 10 MG | Marketed |
| 02245073 | CORICIDIN D FLU, NASAL AND SINUS | SCHERING-PLOUGH HEALTHCARE PRODUCTS CANADA, A DIVISION OF SCHERING CANADA INC. | Tablet | PSEUDOEPHEDRINE SULFATE 30 MG; CHLORPHENIRAMINE MALEATE 2 MG; ACETAMINOPHEN 325 MG | Cancelled Pre Market |
| 00298433 | DRIXORAL COLD & SINUS | BAYER INC CONSUMER CARE | Tablet (Extended-Release) | PSEUDOEPHEDRINE SULFATE 120 MG; DEXBROMPHENIRAMINE MALEATE 6 MG | Cancelled Post Market |
| 02154285 | DRIXORAL DAY/NIGHT - SRT/TABS | SCHERING-PLOUGH CANADA INC | Tablet; Tablet (Extended-Release) | PSEUDOEPHEDRINE SULFATE 120 MG; DEXBROMPHENIRAMINE MALEATE 2 MG; PSEUDOEPHEDRINE SULFATE 60 MG | Cancelled Post Market |
International API supply for PSEUDOEPHEDRINE SULFATE
4 active FDA Drug Master Files.
Request a quote for CORICIDIN D NASAL AND SINUS CONGESTION TABLETS